These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7687221)

  • 1. Effect of recombinant human granulocyte colony-stimulating factor treatment of mice on spleen colony-forming unit number and self-renewal capacity.
    Drize N; Gan O; Zander A
    Exp Hematol; 1993 Aug; 21(9):1289-93. PubMed ID: 7687221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
    Suzuki H; Okano A; Suzuki C; Konishi A; Akiyama Y; Ishibashi T; Ozawa K; Asano S
    Transplantation; 1995 Jun; 59(11):1596-600. PubMed ID: 7539959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic progenitor cell mobilization into the peripheral blood of mice using a combination of recombinant rat stem cell factor (rrSCF) and recombinant human granulocyte colony-stimulating factor (rhG-CSF).
    Drize N; Chertkov J; Zander A
    Exp Hematol; 1995 Oct; 23(11):1180-6. PubMed ID: 7556528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N; Chertkov J; Samoilina N; Zander A
    Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of pegylated recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor on mobilization of hematopoietic progenitor and stem cells with long-term repopulating ability into peripheral blood in mice.
    Honda K; Takenaka K; Shinagawa K; Ishimaru F; Ikeda K; Niiya K; Harada M
    Bone Marrow Transplant; 2001 Aug; 28(4):329-34. PubMed ID: 11571503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term recombinant human granulocyte colony-stimulating factor (rhG-CSF) treatment severely depresses murine marrow erythropoiesis without causing an anemia.
    de Haan G; Loeffler M; Nijhof W
    Exp Hematol; 1992 Jun; 20(5):600-4. PubMed ID: 1375161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on spleen colony-forming unit self-renewal after retroviral-mediated gene transfer of multi-colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, or granulocyte colony-stimulating factor.
    Chang JM; Johnson GR
    Exp Hematol; 1991 Aug; 19(7):602-7. PubMed ID: 1716587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promotion of survival and proliferation by interleukin 3, kit-ligand and erythropoietin on early and late appearing spleen colony forming units in culture.
    Sasaki H; Hirabayashi Y; Inoue T; Taniguchi S; Ikuta K; Matsuyama S
    Stem Cells; 1993 Nov; 11(6):555-61. PubMed ID: 7509224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
    Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated hematopoietic stem and progenitor cell mobilization without depletion of the bone marrow stem and progenitor cell pool in mice after repeated administration of recombinant murine G-CSF.
    de Kruijf EJ; van Pel M; Hagoort H; Kruysdijk D; Molineux G; Willemze R; Fibbe WE
    Hum Immunol; 2007 May; 68(5):368-74. PubMed ID: 17462504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of murine hematopoietic stem/progenitor cell mobilized by recombinant human interleukin 11 combination with granulocyte-colony stimulating factor].
    Meng FY; Jiang ZJ; Yi ZS; Xu D
    Zhonghua Xue Ye Xue Za Zhi; 2003 May; 24(5):225-7. PubMed ID: 12859869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers.
    Huhn RD; Yurkow EJ; Tushinski R; Clarke L; Sturgill MG; Hoffman R; Sheay W; Cody R; Philipp C; Resta D; George M
    Exp Hematol; 1996 Jun; 24(7):839-47. PubMed ID: 8647235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival of lethally irradiated recipient mice transplanted with circulating progenitor cells mobilized by IL-8 after pretreatment with stem cell factor.
    Laterveer L; Zijlmans JM; Lindley IJ; Hamilton MS; Willemze R; Fibbe WE
    Exp Hematol; 1996 Oct; 24(12):1387-93. PubMed ID: 8913284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemopoietic effects of short-term in vivo treatment of mice with various doses of rhG-CSF.
    Pojda Z; Molineux G; Dexter TM
    Exp Hematol; 1990 Jan; 18(1):27-31. PubMed ID: 1688807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of erythropoietin to granulocyte colony-stimulating factor after priming chemotherapy enhances hemopoietic progenitor mobilization.
    Olivieri A; Offidani M; Cantori I; Ciniero L; Ombrosi L; Masia MC; Brunori M; Montroni M; Leoni P
    Bone Marrow Transplant; 1995 Dec; 16(6):765-70. PubMed ID: 8750267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of rhG-CSF scheduling on megakaryocytopoietic recovery following 5-fluorouracil-induced hematotoxicity in splenectomized B6D2F1 mice.
    Scheding S; Media JE; Nakeff A
    Stem Cells; 1998; 16(2):144-51. PubMed ID: 9554039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
    Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
    Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell responses in myelosuppressed mice following sequential treatment with recombinant human interleukin 1 (rHuIL-1), recombinant murine interleukin 3 (rMuIL-3) and recombinant human macrophage colony-stimulating factor (rHuM-CSF).
    Kovacs CJ; Harrell JP; Evans MJ; Abernathy RS; Roberts CJ; Johnke RM
    Stem Cells; 1994 Jan; 12(1):103-13. PubMed ID: 8142915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.